SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-017669
Filing Date
2011-03-28
Accepted
2011-03-28 17:22:07
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v216187_10k.htm 10-K 1978984
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v216187_chrt-line.jpg GRAPHIC 33240
5 v216187_ex10-24.htm EX-10.24 62771
6 v216187_ex23-1.htm EX-23.1 4562
7 v216187_ex31-1.htm EX-31.1 13719
8 v216187_ex31-2.htm EX-31.2 12607
9 v216187_ex32-1.htm EX-32.1 5709
10 v216187_ex32-2.htm EX-32.2 5951
  Complete submission text file 0001144204-11-017669.txt   2131636
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 11716682
SIC: 2836 Biological Products, (No Diagnostic Substances)